Sierra oncology, inc. (SRRA)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss

-107,155

-88,275

-55,096

-48,910

-54,842

-53,335

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Net loss

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-50,077

-53,373

-55,750

-53,260

0

0

0

Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Changes in fair value of warrant liabilities

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

17,443

0

0

0

Securities issuance obligation

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Stock-based compensation

4,914

5,695

6,431

6,972

6,996

6,796

6,509

6,148

5,877

5,905

6,043

5,882

5,674

5,510

0

0

0

-

-

-

-

Depreciation and amortization

76

83

214

178

144

111

115

161

234

258

274

247

198

197

191

178

150

111

0

0

0

Other

-189

-161

2

-98

135

68

166

156

-37

-31

-9

-10

-37

-15

-69

-47

-38

-34

0

0

0

Changes in operating assets and liabilities:
Prepaid expenses and other assets

-1,768

-336

-74

1,369

1,549

1,341

1,463

1,854

1,478

115

2

134

-291

362

1,236

423

1,401

1,087

0

0

0

Accrued, other and operating lease liabilities

-957

-2,034

-667

-59

1,432

2,770

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Accrued liabilities

-

-

-

-

-

-

-

-

-

990

-8,216

-1,254

-1,265

-1,713

11,089

4,494

4,127

5,302

0

0

0

Accounts payable

747

-277

345

80

-118

-48

505

606

-362

-1,217

337

-165

-621

2,246

-661

-56

-160

6

0

0

0

Net cash used in operating activities

-49,565

-51,183

-48,701

-51,860

-48,072

-45,115

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

CASH FLOWS FROM INVESTING ACTIVITIES:
Net cash used in operating activities

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-34,575

-35,583

-32,510

-28,265

0

0

0

Purchase of property and equipment

-

39

0

0

0

-

-

-

-

92

110

108

113

214

229

353

581

414

0

0

0

Change in restricted cash

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-25

-25

75

150

0

0

0

Net cash used in investing activities

-

-39

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from exercise of common stock options

-

445

447

492

524

180

321

276

244

166

0

0

0

-

-

-

-

18

0

0

0

Purchase of short-term investments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

21

0

0

0

Net cash used in investing activities

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-161

9,713

9,363

9,446

0

0

0

Proceeds from issuance of common stock upon follow-on offering, net of offering costs

-

-

-

-

-

45,996

45,996

45,996

45,996

27,422

0

0

0

-

-

-

-

-

-

-

-

Payment of deferred offering costs

-

-

-

-

-

-

-

-

-

-

-

-

-

15

0

0

0

-

-

-

-

Net cash provided by financing activities

-

92,738

447

5,447

5,479

51,131

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Payment of deferred offering costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

Proceeds from early exercise of stock options

-

-

-

-

-

-

-

-

-

-

-

-

-

-

194

120

96

13

0

0

0

Net cash provided by financing activities

-

-

-

-

-

-

-

-

-

-

-

-

0

-

179

140,678

140,000

139,876

0

0

0

Effect of exchange rate changes on cash, cash equivalents and restricted cash

-77

-34

-88

-74

-71

-88

-46

-40

-26

-4

0

0

0

-

-

-

-

-

-

-

-

NET (DECREASE) IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH

42,626

41,482

-48,434

-46,594

-42,796

5,810

8,417

8,839

8,792

-8,671

0

0

0

-

-

-

-

-

-

-

-

Effect of exchange rate changes on cash and cash equivalents

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-34,626

114,750

116,817

121,026

0

0

0

SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:
Cash paid for (refund of) income taxes, net

-26

-69

-95

-110

-87

15

54

177

243

260

0

0

0

-

-

-

-

8

0

0

0

Cash paid for interest

-

336

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

SUPPLEMENTAL DISCLOSURES OF NON-CASH INVESTING AND FINANCING INFORMATION:
Issuance of common stock and common stock warrant in connection with an amendment to the asset purchase agreement

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Reclassification of warrant liabilities to equity

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Right-of-use asset obtained in exchange for operating lease obligation

-

771

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Unpaid property and equipment in accrued and other liabilities

0

-

-

-

-

-

-

-

18

4

80

84

72

85

0

0

0

-

-

-

-

Unpaid deferred financing costs in accrued and other liabilities

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Offering costs included in accrued and other liabilities

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Change in redemption value of redeemable convertible preferred stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Offering costs included in accounts payable and accrued liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0